Superworth

Warby Parker price to free cash flow WRBY

Market value divided by free cash flow over the last twelve months, since 2023.

Today, Nov 2, 2026
136×
3-year median
82.5×
Against its 3-year history
86th
percentile: 0 is its lowest day, 100 its highest
3-year range
45.1× to 220×
Peer median
24.8×

Warby Parker's price to free cash flow is 136× as of Nov 2, 2026.

That is above its 3-year median of 82.5×, higher than on 86% of days in the last 3 years.

Over that time it ranged from 45.1× in May 2025 to 220× in Mar 2024.

The median for 10 medical instruments and supplies stocks of a similar size is 24.8×.

Price to free cash flow over time

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
2026 so far136×56.8×156×
202578.2×45.1×102×
202490.1×65.4×220×
202398.4×70.2×98.4×

Against its peers

Companies in Medical - Instruments & Supplies nearest Warby Parker's size, closest first, today.

CompanyPrice to free cash flow
WRBYWarby Parker136×
ATRCAtriCure57.3×
UFPTUFP Technologiesn/m
NVSTEnvista16.0×
ICUIICU Medical26.6×
INSPInspire Medical Systems16.6×
BMIBadger Meter31.6×
LMATLemaitre Vascular25.2×
VNTVontier12.9×
MMSIMerit Medical Systems24.8×
HAEHaemonetics18.8×
Peer median24.8×

What the price to free cash flow tells you

Market value divided by free cash flow: the cash left after running the business and paying for equipment. Cash is harder to manage than accounting earnings, so many investors trust this more than PE.

Lumpy: a big year of building factories drops cash flow and inflates the ratio without the business getting worse.

More on Warby Parker

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.